INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.72B / 19S · 11 late91 trades$22.97M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10CMCannon-Brookes Michael35B / 0S35 trades$11.72M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,187 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CC
Canale-Theakston CarinDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
875 sh
Jan 7, 2026Jan 7, 2026
Page 1567 of 1855
← PrevNext →
traded Jan 7, 2026
+0d
SEC Form 4

Evidence

9
GJ
Gotwals Philip JDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
SR
Spencer RyanDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
2,125 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
TE
Taylor Timothy EvanDirector, VP, Finance & Operations
GSATGlobalstar, Inc.
Grant or award
A—
6,666 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
WG
Watkinson David GeorgeDirector, CEO and President
RYESRise Gold Corp.
Disposition to issuer
D—
250.0K sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

9
KA
Knutson AnnChief Human Resources Officer
EQBKEQUITY BANCSHARES INC
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
AG
Auwaerter Paul GisbertDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
BL
Bolger LesleySee Remarks
THRYThryv Holdings, Inc.
Tax withholding
F$29K
5,047 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
SR
Spencer RyanDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
11.1K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
SK
Slupkowski KrzysztofChief Credit Officer
EQBKEQUITY BANCSHARES INC
Grant or award
A—
23.2K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
DN
Davarpanah Nicole NegarChief Medical Officer
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
30.0K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
AG
Auwaerter Paul GisbertDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
5,420 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
CK
Connors Michele KimGeneral Counsel
AMBQAmbiq Micro, Inc.
Grant or award
A—
23.8K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
KM
Kelliher MikeDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
AG
Auwaerter Paul GisbertDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
1,360 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
BM
Buten MatthewChief Financial Officer
BHVNBiohaven Ltd.
Tax withholding
F$26K
2,594 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
CT
Cabot Jeffrey TChief Accounting Officer
STEMSTEM, INC.
Grant or award
A—
3,500 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
BG
Braca GregoryDirector
IDNIntellicheck, Inc.
Grant or award
A—
3,925 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
MM
Merchant ManishaEVP / Chief Legal Officer
BCALCalifornia BanCorp \ CA
Tax withholding
F$23K
1,238 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

9
HW
Hornbuckle WilliamDirector
GBFHGBank Financial Holdings Inc.
Grant or award
A$6,380
178 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

9
VC
Voinovich Michael CDirector
GBFHGBank Financial Holdings Inc.
Grant or award
A$10K
280 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

9
DN
Davarpanah Nicole NegarChief Medical Officer
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
8,333 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
CC
Canale-Theakston CarinDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
2,125 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
AK
Ammerman Douglas KDirector
FGF&G Annuities & Life, Inc.
Grant or award
A—
762 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
CT
Cabot Jeffrey TChief Accounting Officer
STEMSTEM, INC.
Grant or award
A—
3,500 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
HE
Hall Justin EEVP
NDSNNORDSON CORP
Tax withholding
F$15K
63 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
EL
Engstrom Jamie LDirector
AEEAMEREN CORP
Grant or award
A—
1,686 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
WG
Watkinson David GeorgeDirector, CEO and President
RYESRise Gold Corp.
Grant or award
A—
250.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
MJ
Merson JamesDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
2,125 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
WG
Watkinson David GeorgeDirector, CEO and President
RYESRise Gold Corp.
Grant or award
A—
250.0K sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

9
PJ
Pace Philip JSVP, Chief Accounting Officer
BLMNBloomin' Brands, Inc.
Grant or award
A—
23.1K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
DM
David Bryant MitchellChief Wholesale Banking Office
FNBFNB CORP/PA/
Tax withholding
F$29K
1,690 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

9
NJ
Nolan Michael JosephDirector
FGF&G Annuities & Life, Inc.
Grant or award
A—
941 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
GC
Griffith Curtis CDirector, Chairman and CEO
SPFISOUTH PLAINS FINANCIAL, INC.
Grant or award
A—
10.6K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
MS
McGinnis Eric SPresident, Climate Solutions
MODMODINE MANUFACTURING CO
Option exercise
M—
9,069 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
MS
McGinnis Eric SPresident, Climate Solutions
MODMODINE MANUFACTURING CO
Option exercise
M—
14.2K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
MS
McGinnis Eric SPresident, Climate Solutions
MODMODINE MANUFACTURING CO
Option exercise
M—
2,071 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
DN
Davarpanah Nicole NegarChief Medical Officer
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
11.0K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
MJ
Merson JamesDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
11.1K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence